MicroPort Completes the First Bilateral SuperPath™ THA in China

Shanghai, China – 25 December, 2014 – Shanghai MicroPort Medical (Group) Co ("MicroPort") recently completed its first bilateral SuperPath™ Micro-posterior Total Hip Arthroplasty ("THA") in China.
 
The surgery, carried out by Professor Yanguo Qin in the Second Hospital of Jilin University, was a success. The patient, who suffered from bilateral femoral head necrosis, was back on his feet on the second day of the surgery and has started rehabilitative training.
 
According to Professor Qin, this surgery proved SuperPath™ surgical technique’s advantage in preventing the risk of dislocation in posterior approach of hip replacement. Professor Qin said, at the end of the surgery, he tested dislocation in each angle and found out the patient’s posterolateral hip was in stable condition.
 
SuperPath™ is a revolutionary surgical technique, as it is designed to precisely reconstruct the hip without cutting critical tendons and stretching or traumatizing muscles that are important to hip function. With SuperPath™, there is no surgical dislocation of the hip and the integrity of the capsule is completely preserved. Because of the elimination of damage to the important structures during reconstruction, patients typically have a short hospital stay.
 
With an aging population, there will be a growing demand for joint replacement surgeries in China and we believe SuperPath™ surgical techniques will benefit more Chinese patients in the future.